Changing patterns of infection in cancer patients.
D001424:Bacterial Infections / Q000150:complications* / Q000188:drug therapy; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004926:Escherichia coli / Q000302:isolation & purification; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications; D008826:Microbial Sensitivity Tests; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D013210:Staphylococcus / Q000302:isolation & purification
D005839:Gentamicins; D002981:Clindamycin; D002228:Carbenicillin; D002512:Cephalothin